首页 > 最新文献

Research methods in medicine & health sciences最新文献

英文 中文
Choice of Link Functions for Generalized Linear Mixed Models in Meta-Analyses of Proportions. 比例元分析中广义线性混合模型连接函数的选择。
Pub Date : 2025-01-01 Epub Date: 2023-12-27 DOI: 10.1177/26320843231224808
Lianne K Siegel, Milena Silva, Lifeng Lin, Yong Chen, Yu-Lun Liu, Haitao Chu

Two-step approaches for synthesizing proportions in a meta-analysis require first transforming the proportions to a scale where their distribution across studies can be approximated by a normal distribution. Commonly used transformations include the log, logit, arcsine, and Freeman-Tukey double-arcsine transformations. Alternatively, a generalized linear mixed model (GLMM) can be fit directly on the data using the exact binomial likelihood. Unlike popular two-step methods, this accounts for uncertainty in the within-study variances without a normal approximation and does not require an ad hoc correction for zero counts. However, GLMMs require choosing a link function; we illustrate how the AIC can be used to choose the best-fitting link when different link functions give different results. We also highlight how misspecification of the link function can introduce bias; using an empirical sandwich estimator for the standard error may not sufficiently avoid undercoverage due to link function misspecification. We demonstrate the application of GLMMs and choice of link function using data from a systematic review on the prevalence of fever in children with COVID-19.

在荟萃分析中综合比例的两步法要求首先将比例转换成一个尺度,使其在不同研究中的分布可以近似于正态分布。常用的转换包括对数、对数、弧线和 Freeman-Tukey 双弧线转换。另外,也可以使用精确二项似然法在数据上直接拟合广义线性混合模型(GLMM)。与流行的两步法不同,这种方法无需正态近似就能考虑到研究内方差的不确定性,也不需要对零计数进行特别校正。然而,GLMM 需要选择一个链接函数;我们将说明当不同的链接函数给出不同的结果时,如何使用 AIC 来选择最佳拟合链接。我们还强调了链接函数的错误指定会如何带来偏差;使用经验三明治估计标准误差可能无法充分避免链接函数错误指定导致的覆盖不足。我们使用 COVID-19 儿童发热患病率的系统综述数据来演示 GLMMs 的应用和链接函数的选择。
{"title":"Choice of Link Functions for Generalized Linear Mixed Models in Meta-Analyses of Proportions.","authors":"Lianne K Siegel, Milena Silva, Lifeng Lin, Yong Chen, Yu-Lun Liu, Haitao Chu","doi":"10.1177/26320843231224808","DOIUrl":"10.1177/26320843231224808","url":null,"abstract":"<p><p>Two-step approaches for synthesizing proportions in a meta-analysis require first transforming the proportions to a scale where their distribution across studies can be approximated by a normal distribution. Commonly used transformations include the log, logit, arcsine, and Freeman-Tukey double-arcsine transformations. Alternatively, a generalized linear mixed model (GLMM) can be fit directly on the data using the exact binomial likelihood. Unlike popular two-step methods, this accounts for uncertainty in the within-study variances without a normal approximation and does not require an <i>ad hoc</i> correction for zero counts. However, GLMMs require choosing a link function; we illustrate how the AIC can be used to choose the best-fitting link when different link functions give different results. We also highlight how misspecification of the link function can introduce bias; using an empirical sandwich estimator for the standard error may not sufficiently avoid undercoverage due to link function misspecification. We demonstrate the application of GLMMs and choice of link function using data from a systematic review on the prevalence of fever in children with COVID-19.</p>","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"6 1","pages":"13-23"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142820442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disclosure of suicidal ideation in non-psychiatric clinical research: Experience using a novel suicide risk management algorithm in a multi-center smoking cessation trial 非精神病学临床研究中自杀意念的披露:在多中心戒烟试验中使用新型自杀风险管理算法的经验
Pub Date : 2023-11-04 DOI: 10.1177/26320843231212427
Kelsey L Schertz, Megan Petrik, Mariah Branson, Steven S Fu, Alexander J Rothman, Abbie Begnaud, Anne M Joseph
Background Clinical trials involving pharmacologic or behavioral treatments often assess depression and suicidal ideation for purposes of screening, baseline assessment of potential moderators or mediators of treatment, or as a study outcome, even if the primary condition under study is not a mental health disorder. Suicide risk management in the context of clinical research poses significant clinical, ethical, and practical challenges, and the literature provides little guidance with respect to outcomes of suicide risk management protocols (SRMPs) or suicide risk assessment instruments deployed in the clinical research setting. Methods We report our experience using a novel SRMP in the Program for Lung Cancer Screening and Tobacco Cessation (PLUTO) trial through in-person and remote interactions. Results An SRMP was developed for non-clinical research staff to assess and respond to participants who express suicidal ideation. Between September 2016 and April 2021, the SRMP was used 61 times for 59 individuals. The SRMP was activated by explicit probing of suicidal ideation in 46 of 61 uses (75%). Subject risk was categorized as high-risk in 6 of 61 SRMP uses (10%). Conclusion Our findings demonstrate a useful tool for the management of suicidal ideation and behavior in a clinical trial. Suicidal ideation may be endorsed by only a small number of study participants, however participant safety dictates the need to develop and implement a practical SRMP. These findings may be of relevance to researchers collecting patient reported outcomes remotely. Researchers should consider available resources for SRMPs during design and start-up phases of research.
背景:涉及药物或行为治疗的临床试验经常评估抑郁和自杀意念,以筛选、基线评估潜在的治疗调节或中介因素,或作为研究结果,即使研究的主要情况不是精神健康障碍。临床研究背景下的自杀风险管理带来了重大的临床、伦理和实践挑战,并且文献对在临床研究环境中部署的自杀风险管理协议(SRMPs)或自杀风险评估工具的结果提供了很少的指导。方法:我们报告了我们在肺癌筛查和戒烟项目(PLUTO)试验中通过面对面和远程互动使用新型SRMP的经验。结果为非临床研究人员开发了一个SRMP来评估和回应表达自杀意念的参与者。在2016年9月至2021年4月期间,SRMP被使用了61次,共有59人。在61例使用中,有46例(75%)被自杀意念的外显试探激活SRMP。61例SRMP使用中有6例(10%)受试者风险被归类为高风险。结论本研究结果为临床试验中自杀意念和行为的管理提供了一个有用的工具。自杀意念可能只有少数研究参与者认可,然而参与者的安全要求需要制定和实施一个实用的SRMP。这些发现可能与研究人员远程收集患者报告的结果有关。研究人员应在研究的设计和启动阶段考虑srmp的可用资源。
{"title":"Disclosure of suicidal ideation in non-psychiatric clinical research: Experience using a novel suicide risk management algorithm in a multi-center smoking cessation trial","authors":"Kelsey L Schertz, Megan Petrik, Mariah Branson, Steven S Fu, Alexander J Rothman, Abbie Begnaud, Anne M Joseph","doi":"10.1177/26320843231212427","DOIUrl":"https://doi.org/10.1177/26320843231212427","url":null,"abstract":"Background Clinical trials involving pharmacologic or behavioral treatments often assess depression and suicidal ideation for purposes of screening, baseline assessment of potential moderators or mediators of treatment, or as a study outcome, even if the primary condition under study is not a mental health disorder. Suicide risk management in the context of clinical research poses significant clinical, ethical, and practical challenges, and the literature provides little guidance with respect to outcomes of suicide risk management protocols (SRMPs) or suicide risk assessment instruments deployed in the clinical research setting. Methods We report our experience using a novel SRMP in the Program for Lung Cancer Screening and Tobacco Cessation (PLUTO) trial through in-person and remote interactions. Results An SRMP was developed for non-clinical research staff to assess and respond to participants who express suicidal ideation. Between September 2016 and April 2021, the SRMP was used 61 times for 59 individuals. The SRMP was activated by explicit probing of suicidal ideation in 46 of 61 uses (75%). Subject risk was categorized as high-risk in 6 of 61 SRMP uses (10%). Conclusion Our findings demonstrate a useful tool for the management of suicidal ideation and behavior in a clinical trial. Suicidal ideation may be endorsed by only a small number of study participants, however participant safety dictates the need to develop and implement a practical SRMP. These findings may be of relevance to researchers collecting patient reported outcomes remotely. Researchers should consider available resources for SRMPs during design and start-up phases of research.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"12 10","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135774560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamic relationship among immediate release fentanyl use and cancer incidence: A multivariate time-series analysis using vector autoregressive models 即时释放芬太尼使用与癌症发病率的动态关系:使用向量自回归模型的多变量时间序列分析
Pub Date : 2023-10-17 DOI: 10.1177/26320843231206357
Diana González-Bermejo, Belén Castillo-Cano, Alfonso Rodríguez-Pascual, Pilar Rayón-Iglesias, Dolores Montero-Corominas, Consuelo Huerta-Álvarez
Background: A substantial increase in the incidence of immediate release fentanyl (IRF) use was reported in Spain from 2012 to 2017. Purpose: This study aimed to investigate the relationship dynamically with cancer incidence in order to provide empirical evidence of inappropriate use of IRF with respect to the pathology. Research design: A vector autoregresive (VAR) model was constructed using data from a nationwide electronic healthcare record database in primary care in Spain (BIFAP) according to the following step procedure: (1) split data into training data for modelling and test for validation (2) assessing for time series stationarity; (3) selecting lag-length; (4) building the VAR model; (5) assessing residual autocorrelation; (6) checking stability of the VAR system; (7) evaluating Granger causality; (8) impulse response analysis and forecast error variance decomposition (9) prediction performance with validation data. Results: The analysis showed a strong and linear correlation between IRF and cancer (Pearson correlation coefficient: 0.594 (95% CI: 0.420–0.726). Two VAR models, VAR (2) and VAR (11) were selected and compared. All tests performed for both models satisfied assumptions for stability, predictability and accuracy. Granger causality revealed cancer incidence is a good predictor for IRF use. VAR (2) seemed to be slightly more accurate, according to the RMSE of the test data. Conclusions: This study demonstrates that using a robust and structured VAR modelling approach, is able to estimate dynamics associations, involving IRF use and cancer incidence.
背景:据报道,从2012年到2017年,西班牙立即释放芬太尼(IRF)的使用发生率大幅增加。目的:本研究旨在动态探讨IRF与肿瘤发病率的关系,为IRF在病理上的不当使用提供经验证据。研究设计:使用西班牙全国初级保健电子医疗记录数据库(BIFAP)的数据,按照以下步骤构建向量自回归(VAR)模型:(1)将数据分成训练数据进行建模和验证检验;(2)评估时间序列平稳性;(3)选择滞后长度;(4)建立VAR模型;(5)残差自相关评估;(6)检查VAR系统的稳定性;(7)格兰杰因果关系评价;(8)脉冲响应分析与预测误差方差分解(9)利用验证数据预测性能。结果:分析显示IRF与癌症之间有很强的线性相关性(Pearson相关系数:0.594 (95% CI: 0.420-0.726)。选取VAR(2)和VAR(11)两个VAR模型进行比较。对两种模型进行的所有测试都满足稳定性、可预测性和准确性的假设。格兰杰因果关系显示,癌症发病率是IRF使用的良好预测因子。根据测试数据的RMSE, VAR(2)似乎更准确一些。结论:本研究表明,使用稳健和结构化的VAR建模方法,能够估计涉及IRF使用和癌症发病率的动态关联。
{"title":"Dynamic relationship among immediate release fentanyl use and cancer incidence: A multivariate time-series analysis using vector autoregressive models","authors":"Diana González-Bermejo, Belén Castillo-Cano, Alfonso Rodríguez-Pascual, Pilar Rayón-Iglesias, Dolores Montero-Corominas, Consuelo Huerta-Álvarez","doi":"10.1177/26320843231206357","DOIUrl":"https://doi.org/10.1177/26320843231206357","url":null,"abstract":"Background: A substantial increase in the incidence of immediate release fentanyl (IRF) use was reported in Spain from 2012 to 2017. Purpose: This study aimed to investigate the relationship dynamically with cancer incidence in order to provide empirical evidence of inappropriate use of IRF with respect to the pathology. Research design: A vector autoregresive (VAR) model was constructed using data from a nationwide electronic healthcare record database in primary care in Spain (BIFAP) according to the following step procedure: (1) split data into training data for modelling and test for validation (2) assessing for time series stationarity; (3) selecting lag-length; (4) building the VAR model; (5) assessing residual autocorrelation; (6) checking stability of the VAR system; (7) evaluating Granger causality; (8) impulse response analysis and forecast error variance decomposition (9) prediction performance with validation data. Results: The analysis showed a strong and linear correlation between IRF and cancer (Pearson correlation coefficient: 0.594 (95% CI: 0.420–0.726). Two VAR models, VAR (2) and VAR (11) were selected and compared. All tests performed for both models satisfied assumptions for stability, predictability and accuracy. Granger causality revealed cancer incidence is a good predictor for IRF use. VAR (2) seemed to be slightly more accurate, according to the RMSE of the test data. Conclusions: This study demonstrates that using a robust and structured VAR modelling approach, is able to estimate dynamics associations, involving IRF use and cancer incidence.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135944365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial 社论
Pub Date : 2023-09-01 DOI: 10.1177/26320843231191835
{"title":"Editorial","authors":"","doi":"10.1177/26320843231191835","DOIUrl":"https://doi.org/10.1177/26320843231191835","url":null,"abstract":"","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"123 - 123"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49162009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring metrics over time: Why clinical trialists need to systematically collect site performance metrics. 随时间监控指标:为什么临床试验人员需要系统地收集站点性能指标。
Pub Date : 2023-09-01 Epub Date: 2022-12-21 DOI: 10.1177/26320843221147855
Victoria Yorke-Edwards, Carlos Diaz-Montana, Macey L Murray, Matthew R Sydes, Sharon B Love

Background: Over the last decade, there has been an increasing interest in risk-based monitoring (RBM) in clinical trials, resulting in a number of guidelines from regulators and its inclusion in ICH GCP. However, there is a lack of detail on how to approach RBM from a practical perspective, and insufficient understanding of best practice.

Purpose: We present a method for clinical trials units to track their metrics within clinical trials using descriptive statistics and visualisations.

Research design: We suggest descriptive statistics and visualisations within a SWAT methodology.

Study sample: We illustrate this method using the metrics from TEMPER, a monitoring study carried out in three trials at the MRC Clinical Trials Unit at UCL.

Data collection: The data collection for TEMPER is described in DOI: 10.1177/1740774518793379.

Results: We show the results and discuss a protocol for a Study-Within-A-Trial (SWAT 167) for those wishing to use the method.

Conclusions: The potential benefits metric tracking brings to clinical trials include enhanced assessment of sites for potential corrective action, improved evaluation and contextualisation of the influence of metrics and their thresholds, and the establishment of best practice in RBM. The standardisation of the collection of such monitoring data would benefit both individual trials and the clinical trials community.

背景:在过去的十年里,人们对临床试验中基于风险的监测(RBM)越来越感兴趣,监管机构制定了一些指导方针,并将其纳入ICH GCP。然而,缺乏关于如何从实际角度处理成果管理制的细节,对最佳做法的了解也不够。目的:我们为临床试验单位提供了一种方法,使用描述性统计和可视化来跟踪临床试验中的指标。研究设计:我们建议在SWAT方法中进行描述性统计和可视化。研究样本:我们使用TEMPER的指标来说明这种方法,TEMPER是一项在伦敦大学学院MRC临床试验部的三项试验中进行的监测研究。数据收集:TEMPER的数据收集在DOI:10.1177/1707774518793379中进行了描述。结果:我们展示了结果,并讨论了希望使用该方法的人的Study-Within-a-Trial(SWAT 167)方案。结论:指标跟踪为临床试验带来的潜在益处包括加强对潜在纠正措施地点的评估,改进对指标及其阈值影响的评估和情境化,以及建立RBM的最佳实践。此类监测数据收集的标准化将有利于个体试验和临床试验界。
{"title":"Monitoring metrics over time: Why clinical trialists need to systematically collect site performance metrics.","authors":"Victoria Yorke-Edwards,&nbsp;Carlos Diaz-Montana,&nbsp;Macey L Murray,&nbsp;Matthew R Sydes,&nbsp;Sharon B Love","doi":"10.1177/26320843221147855","DOIUrl":"10.1177/26320843221147855","url":null,"abstract":"<p><strong>Background: </strong>Over the last decade, there has been an increasing interest in risk-based monitoring (RBM) in clinical trials, resulting in a number of guidelines from regulators and its inclusion in ICH GCP. However, there is a lack of detail on how to approach RBM from a practical perspective, and insufficient understanding of best practice.</p><p><strong>Purpose: </strong>We present a method for clinical trials units to track their metrics within clinical trials using descriptive statistics and visualisations.</p><p><strong>Research design: </strong>We suggest descriptive statistics and visualisations within a SWAT methodology.</p><p><strong>Study sample: </strong>We illustrate this method using the metrics from TEMPER, a monitoring study carried out in three trials at the MRC Clinical Trials Unit at UCL.</p><p><strong>Data collection: </strong>The data collection for TEMPER is described in <i>DOI: 10.1177/1740774518793379</i>.</p><p><strong>Results: </strong>We show the results and discuss a protocol for a Study-Within-A-Trial (SWAT 167) for those wishing to use the method.</p><p><strong>Conclusions: </strong>The potential benefits metric tracking brings to clinical trials include enhanced assessment of sites for potential corrective action, improved evaluation and contextualisation of the influence of metrics and their thresholds, and the establishment of best practice in RBM. The standardisation of the collection of such monitoring data would benefit both individual trials and the clinical trials community.</p>","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 4","pages":"124-135"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615148/pdf/EMS187694.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41143086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial 社论
Pub Date : 2023-07-01 DOI: 10.5784/39-1-764
J. Visagie
{"title":"Editorial","authors":"J. Visagie","doi":"10.5784/39-1-764","DOIUrl":"https://doi.org/10.5784/39-1-764","url":null,"abstract":"","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"86 - 86"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43475782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of caller ID and text messaging from cell phones to increase response rates in patient surveys 使用来电显示和手机短信来提高患者调查的应答率
Pub Date : 2023-04-03 DOI: 10.1177/26320843231167496
Luke E Peters, Jie Zhao, Scott Gelzinnis, Stephen R Smith, Jennifer Martin, P. Pockney
Background: High response rates for patient surveys are required in medical literature to ensure non-response bias is minimised. It is often difficult to achieve a satisfactory response rate as patient engagement in surveys is decreasing. A major barrier to phone surveys is getting patients to answer calls from unknown numbers. Purpose: To design a methodology which boosts response rates for telephone-based patient surveys. Research Design: We prospectively analysed the effectiveness of our methodology for increasing patient participation using caller ID and text messanging. Study Sample: Two waves totalling 1313 patients were contacted for participation in a patient survey for a descriptive quantitative and qualitative cohort study using our developed methadology. Data Analysis: We analysed the timepoints at which successful contact was made when using caller ID and text messanging. Results: We achieved a call answer rate of 85.4%, which was a 70.8% increase when compared to a similar patient cohort contacted via blocked caller ID (i.e. with privacy settings). Conclusion: We have developed a simple, inexpensive methodology which, when tested outside the Australian setting and for other projects, shows promise for increasing patient survey response rate.
背景:医学文献要求患者调查的高应答率,以确保最大限度地减少无应答偏差。由于患者参与调查的程度越来越低,通常很难达到令人满意的应答率。电话调查的一个主要障碍是让患者接听未知号码的电话。目的:设计一种方法,提高基于电话的患者调查的响应率。研究设计:我们前瞻性地分析了我们使用来电显示和短信增加患者参与度的方法的有效性。研究样本:使用我们开发的美沙酮学,接触了两波共1313名患者,参与了一项描述性定量和定性队列研究的患者调查。数据分析:我们分析了在使用来电显示和短信时成功联系的时间点。结果:我们实现了85.4%的呼叫应答率,与通过屏蔽来电显示(即使用隐私设置)联系的类似患者队列相比,这一比率增加了70.8%。结论:我们开发了一种简单、廉价的方法,当在澳大利亚以外的环境和其他项目中进行测试时,该方法有望提高患者调查的响应率。
{"title":"Use of caller ID and text messaging from cell phones to increase response rates in patient surveys","authors":"Luke E Peters, Jie Zhao, Scott Gelzinnis, Stephen R Smith, Jennifer Martin, P. Pockney","doi":"10.1177/26320843231167496","DOIUrl":"https://doi.org/10.1177/26320843231167496","url":null,"abstract":"Background: High response rates for patient surveys are required in medical literature to ensure non-response bias is minimised. It is often difficult to achieve a satisfactory response rate as patient engagement in surveys is decreasing. A major barrier to phone surveys is getting patients to answer calls from unknown numbers. Purpose: To design a methodology which boosts response rates for telephone-based patient surveys. Research Design: We prospectively analysed the effectiveness of our methodology for increasing patient participation using caller ID and text messanging. Study Sample: Two waves totalling 1313 patients were contacted for participation in a patient survey for a descriptive quantitative and qualitative cohort study using our developed methadology. Data Analysis: We analysed the timepoints at which successful contact was made when using caller ID and text messanging. Results: We achieved a call answer rate of 85.4%, which was a 70.8% increase when compared to a similar patient cohort contacted via blocked caller ID (i.e. with privacy settings). Conclusion: We have developed a simple, inexpensive methodology which, when tested outside the Australian setting and for other projects, shows promise for increasing patient survey response rate.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"150 - 155"},"PeriodicalIF":0.0,"publicationDate":"2023-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46868128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using network meta-analysis to predict the percentage of missing participants for a future trial 使用网络荟萃分析预测未来试验中失踪参与者的百分比
Pub Date : 2023-03-29 DOI: 10.1177/26320843231167502
L. Spineli
Background Using evidence synthesis to design a clinical trial has long been advocated as the key against research waste. However, the relevant methodology does not deal with possible missing participants (MP) that may occur in a future trial. We illustrated the synergism of the baseline effects model and network meta-analysis (NMA) to predict the percentage of MP for a future trial. Methods We considered the network of a published systematic review as a case study. We applied the baseline effects model, followed by the relative effects model using Bayesian methods to predict the percentage of MP in each intervention when conducting NMA and a series of pairwise meta-analyses. We illustrated the posterior distribution of the predicted percentage MP under both synthesis methods alongside the MP reported in the corresponding trials for each intervention. Results Selecting different interventions for the baseline effects model yielded different predicted baseline effects and led to different predicted percentages of MP for the remaining interventions, highlighting the need to carefully pre-specifying the intervention for the baseline effects model. Both synthesis methods provided almost identical posterior distributions of predicted percentage MP for estimating similar summary odds ratios. There was great variability in the percentage of MP across the trials for each intervention, manifesting as considerable variability in the percentage difference in MP compared to NMA. Conclusions Incorporating predictions and absolute effects in the context of MP in NMA aids in determining the anticipated percentage of MP in the compared interventions to plan a future trial efficiently.
长期以来,利用证据综合来设计临床试验一直被认为是防止研究浪费的关键。然而,相关的方法并没有处理在未来的试验中可能出现的缺失参与者(MP)。我们说明了基线效应模型和网络荟萃分析(NMA)的协同作用,以预测未来试验的MP百分比。方法我们将一篇已发表的系统综述网络作为案例研究。我们采用基线效应模型,然后采用贝叶斯方法建立相对效应模型,在进行NMA和一系列两两荟萃分析时预测每次干预中MP的百分比。我们展示了两种合成方法下预测的MP百分比的后验分布,以及每种干预措施的相应试验中报告的MP。结果为基线效应模型选择不同的干预措施会产生不同的预测基线效应,并导致剩余干预措施的MP预测百分比不同,这突出了需要仔细预先指定基线效应模型的干预措施。两种合成方法提供了几乎相同的预测百分比MP后验分布,用于估计相似的汇总优势比。在每个干预的试验中,MP的百分比有很大的可变性,与NMA相比,MP的百分比差异有很大的可变性。结论:在NMA中纳入MP背景下的预测和绝对效应有助于确定在比较干预措施中MP的预期百分比,从而有效地计划未来的试验。
{"title":"Using network meta-analysis to predict the percentage of missing participants for a future trial","authors":"L. Spineli","doi":"10.1177/26320843231167502","DOIUrl":"https://doi.org/10.1177/26320843231167502","url":null,"abstract":"Background Using evidence synthesis to design a clinical trial has long been advocated as the key against research waste. However, the relevant methodology does not deal with possible missing participants (MP) that may occur in a future trial. We illustrated the synergism of the baseline effects model and network meta-analysis (NMA) to predict the percentage of MP for a future trial. Methods We considered the network of a published systematic review as a case study. We applied the baseline effects model, followed by the relative effects model using Bayesian methods to predict the percentage of MP in each intervention when conducting NMA and a series of pairwise meta-analyses. We illustrated the posterior distribution of the predicted percentage MP under both synthesis methods alongside the MP reported in the corresponding trials for each intervention. Results Selecting different interventions for the baseline effects model yielded different predicted baseline effects and led to different predicted percentages of MP for the remaining interventions, highlighting the need to carefully pre-specifying the intervention for the baseline effects model. Both synthesis methods provided almost identical posterior distributions of predicted percentage MP for estimating similar summary odds ratios. There was great variability in the percentage of MP across the trials for each intervention, manifesting as considerable variability in the percentage difference in MP compared to NMA. Conclusions Incorporating predictions and absolute effects in the context of MP in NMA aids in determining the anticipated percentage of MP in the compared interventions to plan a future trial efficiently.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"140 - 149"},"PeriodicalIF":0.0,"publicationDate":"2023-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48774129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracing data for systematic reviews and meta-analyses in the advanced age of digital and social media 在数字和社交媒体的先进时代,追踪系统评论和元分析的数据
Pub Date : 2023-03-06 DOI: 10.1177/26320843231162587
Nishadi Gamage, P. Ranasinghe, R. Jayawardena
Background When conducting reviews, obtaining unreported information by contacting corresponding authors via traditional methods of correspondence, such as email/postage has become increasingly challenging. Objective/s The current study aimed to identify the different non-traditional sources and approaches to obtain unreported data from respective authors of primary studies eligible for systematic reviews and meta-analyses. Methods Unreported data were obtained initially through traditional methods (email/telephone, searching forward citations of the articles, review of other publications of the same research team and perusal of authors’ institutional profiles). The second stage included communication through digital/social media, which comprised Facebook, ResearchGate, WhatsApp, Viber, LinkedIn, and the online Global Health Data Exchange (GHDx). Results During data extraction, 41 individual data items were missing/unreported, and we were able to identify 36 (87.8%) during data tracing, using both traditional (n = 10, 27.8%) and digital and social media-based (n = 26, 72.2%) methods. These 26 data items were identified through the following methods, (a) Facebook (n = 6), (b) ResearchGate (n = 3), (c) WhatsApp (n = 3), (d) Viber (n = 1), (e) LinkedIn (n = 1) and GHDx database (n = 12). Conclusion Digital/social media platforms were found to be more successful to obtain unreported data. We believe that a combination of both methods is likely to yield the best results in tracing missing data for systematic reviews. Journals should consider including social media links and non-institutional research profiles in addition to traditional methods for correspondence.
背景在进行审查时,通过传统的通信方式(如电子邮件/邮费)联系通讯作者来获取未报告的信息变得越来越具有挑战性。目的当前的研究旨在确定不同的非传统来源和方法,以从符合系统综述和荟萃分析条件的主要研究的作者那里获得未报告的数据。方法未报告的数据最初是通过传统方法(电子邮件/电话、搜索文章的前引、审查同一研究团队的其他出版物以及仔细阅读作者的机构简介)获得的。第二阶段包括通过数字/社交媒体进行交流,包括Facebook、ResearchGate、WhatsApp、Viber、LinkedIn和在线全球健康数据交换(GHDx)。结果在数据提取过程中,有41个单独的数据项丢失/未报告,在数据追踪过程中,我们能够使用传统方法(n=10,27.8%)和基于数字和社交媒体的方法(n=26,72.2%)识别出36个(87.8%)。这26个数据项是通过以下方法识别的,(a)Facebook(n=6),(b)ResearchGate(n=3),(c)WhatsApp(n=3个),(d)Viber(n=1),(e)LinkedIn(n=1个)和GHDx数据库(n=12个)。结论数字/社交媒体平台在获取未报告数据方面更为成功。我们认为,将这两种方法相结合,可能会在追踪缺失数据以进行系统审查方面产生最佳结果。除了传统的通信方法外,期刊还应考虑包括社交媒体链接和非机构研究简介。
{"title":"Tracing data for systematic reviews and meta-analyses in the advanced age of digital and social media","authors":"Nishadi Gamage, P. Ranasinghe, R. Jayawardena","doi":"10.1177/26320843231162587","DOIUrl":"https://doi.org/10.1177/26320843231162587","url":null,"abstract":"Background When conducting reviews, obtaining unreported information by contacting corresponding authors via traditional methods of correspondence, such as email/postage has become increasingly challenging. Objective/s The current study aimed to identify the different non-traditional sources and approaches to obtain unreported data from respective authors of primary studies eligible for systematic reviews and meta-analyses. Methods Unreported data were obtained initially through traditional methods (email/telephone, searching forward citations of the articles, review of other publications of the same research team and perusal of authors’ institutional profiles). The second stage included communication through digital/social media, which comprised Facebook, ResearchGate, WhatsApp, Viber, LinkedIn, and the online Global Health Data Exchange (GHDx). Results During data extraction, 41 individual data items were missing/unreported, and we were able to identify 36 (87.8%) during data tracing, using both traditional (n = 10, 27.8%) and digital and social media-based (n = 26, 72.2%) methods. These 26 data items were identified through the following methods, (a) Facebook (n = 6), (b) ResearchGate (n = 3), (c) WhatsApp (n = 3), (d) Viber (n = 1), (e) LinkedIn (n = 1) and GHDx database (n = 12). Conclusion Digital/social media platforms were found to be more successful to obtain unreported data. We believe that a combination of both methods is likely to yield the best results in tracing missing data for systematic reviews. Journals should consider including social media links and non-institutional research profiles in addition to traditional methods for correspondence.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"136 - 139"},"PeriodicalIF":0.0,"publicationDate":"2023-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48348143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can learnings from the COVID-19 pandemic improve trial conduct post-pandemic? A case study of strategies used by the DISC trial. 从新冠肺炎大流行中吸取的经验教训能否改善大流行后的试验?DISC试验使用策略的案例研究
Pub Date : 2023-03-01 Epub Date: 2022-09-22 DOI: 10.1177/26320843221128296
Catherine Knowlson, Puvan Tharmanathan, Catherine Arundel, Sophie James, Lydia Flett, Samantha Gascoyne, Charlie Welch, David Warwick, Joseph Dias

Background: RCTs often face issues such as slow recruitment, poor intervention adherence and high attrition, however the 2020/2021 COVID-19 pandemic intensified these challenges. Strategies employed by the DISC trial to overcome pandemic-related barriers to recruitment, treatment delivery and retention may be useful to help overcome routine problems.

Methods: A structured survey and teleconference with sites was undertaken. Key performance indicators in relation to recruitment, treatment delivery and retention were compared descriptively before and after the pandemic started. This was situated also in relation to qualitative opinions of research staff.

Results: Prior to the pandemic, retention was 93.6%. Increased support from the central trial management team and remote data collection methods kept retention rates high at 81.2% in the first 6 months of the pandemic, rising to 89.8% in the subsequent 6 months. Advertising the study to patients resulted in 12.8 patients/month enquiring about participation, however only six were referred to recruiting sites. Sites reported increased support from junior doctors resolved research nurse capacity issues. One site avoided long delays by using theatre space in a private hospital.

Conclusions: Recruitment post-pandemic could be improved by identification of barriers, increased support from junior doctors through the NIHR associate PI scheme and advertising. Remote back-up options for data collection can keep retention high while reducing patient and site burden. To future proof studies against similar disruptions and provide more flexibility for participants, we recommend that RCTs have a back-up option of remote recruitment, a back-up location for surgeries and flexible approaches to collecting data.

随机对照试验经常面临招募缓慢、干预依从性差和高损耗率等问题,而2020/2021年COVID-19大流行加剧了这些挑战。DISC试验为克服与大流行有关的招募、提供治疗和保留治疗方面的障碍所采用的战略,可能有助于克服常规问题。方法采用结构化调查和现场电话会议。在大流行开始前后,描述性地比较了与征聘、提供治疗和留用有关的关键绩效指标。这也与研究人员的定性意见有关。结果流感大流行前的保留率为93.6%。中央试验管理团队的支持和远程数据收集方法的增加使大流行前6个月的保留率保持在81.2%的高位,在随后的6个月上升到89.8%。向患者宣传这项研究导致12.8名患者/月询问参与情况,但只有6名患者被推荐到招募地点。网站报告说,初级医生的支持增加,解决了研究护士能力问题。其中一个场地利用了一家私人医院的剧院空间,避免了长时间的延误。结论大流行后的招募可以通过识别障碍、通过NIHR联合PI计划增加初级医生的支持和广告来改善。数据收集的远程备份选项可以保持高保留,同时减少患者和站点负担。为了防止类似中断的未来证明研究,并为参与者提供更大的灵活性,我们建议随机对照试验有远程招募的备用选择,手术的备用地点和灵活的数据收集方法。
{"title":"Can learnings from the COVID-19 pandemic improve trial conduct post-pandemic? A case study of strategies used by the DISC trial.","authors":"Catherine Knowlson, Puvan Tharmanathan, Catherine Arundel, Sophie James, Lydia Flett, Samantha Gascoyne, Charlie Welch, David Warwick, Joseph Dias","doi":"10.1177/26320843221128296","DOIUrl":"10.1177/26320843221128296","url":null,"abstract":"<p><strong>Background: </strong>RCTs often face issues such as slow recruitment, poor intervention adherence and high attrition, however the 2020/2021 COVID-19 pandemic intensified these challenges. Strategies employed by the DISC trial to overcome pandemic-related barriers to recruitment, treatment delivery and retention may be useful to help overcome routine problems.</p><p><strong>Methods: </strong>A structured survey and teleconference with sites was undertaken. Key performance indicators in relation to recruitment, treatment delivery and retention were compared descriptively before and after the pandemic started. This was situated also in relation to qualitative opinions of research staff.</p><p><strong>Results: </strong>Prior to the pandemic, retention was 93.6%. Increased support from the central trial management team and remote data collection methods kept retention rates high at 81.2% in the first 6 months of the pandemic, rising to 89.8% in the subsequent 6 months. Advertising the study to patients resulted in 12.8 patients/month enquiring about participation, however only six were referred to recruiting sites. Sites reported increased support from junior doctors resolved research nurse capacity issues. One site avoided long delays by using theatre space in a private hospital.</p><p><strong>Conclusions: </strong>Recruitment post-pandemic could be improved by identification of barriers, increased support from junior doctors through the NIHR associate PI scheme and advertising. Remote back-up options for data collection can keep retention high while reducing patient and site burden. To future proof studies against similar disruptions and provide more flexibility for participants, we recommend that RCTs have a back-up option of remote recruitment, a back-up location for surgeries and flexible approaches to collecting data.</p>","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"50-60"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500425/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42414230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Research methods in medicine & health sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1